Magnesium supplementation alleviates corticosteroid-associated muscle atrophy in rats.

Purpose: Corticosteroid (CS) therapy for infectious and rheumatological diseases showed to decrease serum magnesium (Mg++) level and induce muscle atrophy in patients. The present study investigated the effects of Mg++ supplementation on preventing CS-induced muscle atrophy in an animal model, which...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Nutrition Vol. 60; no. 8; pp. 4379 - 4393
Autores principales: Zheng, Lizhen, Huang, Le, Chen, Ziyi, Cui, Can, Zhang, Ri, Qin, Ling
Formato: diagnostic images equations & formulas pictorial research tables/charts Journal Article
Publicado: Springer Nature Dec2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=153436542&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 153436542
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14366207
        CR0
      jtl: European Journal of Nutrition
      issn: 14366207
      maglogo: N
    pubinfo:
      dt: Dec2021
      vid: 60
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        153436542
        150625914
        153436542
        153436542
        10.1007/s00394-021-02598-w
        153436542
      ppf: 4379
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Magnesium supplementation alleviates corticosteroid-associated muscle atrophy in rats.
      aug:
        au:
          Zheng, Lizhen
          Huang, Le
          Chen, Ziyi
          Cui, Can
          Zhang, Ri
          Qin, Ling
        affil: Musculoskeletal Research Laboratory of Department of Orthopaedics and Traumatology and Innovative Orthopaedic Biomaterial and Drug Translational Research Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Rm74026, 5/F, Clinical Science Building, Prince of Wales Hospital, Shatin, Hong Kong SAR, People's Republic of China
      sug:
        subj:
          Dietary Supplementation
          Magnesium Therapeutic Use
          Muscular Atrophy Prevention and Control
          Adrenal Cortex Hormones Adverse Effects
          Muscular Atrophy Chemically Induced
          Animal Studies
          Rats
          Male
          Lipopolysaccharides
          Methylprednisolone
          Absorptiometry, Photon
          Hypomagnesemia
          Fat Free Mass
          Genes
          Body Weights and Measures
          Male
      ab: Purpose: Corticosteroid (CS) therapy for infectious and rheumatological diseases showed to decrease serum magnesium (Mg++) level and induce muscle atrophy in patients. The present study investigated the effects of Mg++ supplementation on preventing CS-induced muscle atrophy in an animal model, which provided experimental data for potential clinical translation. Methods: Twelve 24-week-old male Sprague–Dawley rats were treated with lipopolysaccharide (LPS) and CS methylprednisolone (MPS) to induce muscle atrophy, with half of the rats also given daily 50 mg/kg Mg++ oral supplementation. Additional six rats without LPS + CS treatments were used as normal controls. After treatment for 6 weeks, serum was collected for Mg++ quantification, animal dual-energy X-ray absorptiometry (DXA) was performed for tissue composition, and the extensor digitorum longus (EDL) was collected for muscle functional test and histology including muscle fiber size, intramuscular fat infiltration and fiber typing. In vitro myotube atrophy model was used to study the in vitro effect associated with in vivo muscle atrophy. Results: LPS + CS treatments induced hypomagnesemia while the serum Mg++ level was in normal range after Mg++ supplementation. DXA showed 53.0% lower fat percent and 29.7% higher lean mass in LPS + CS + Mg group when compared to LPS + CS group. Muscle functional test showed 22.2% higher specific twitch force and 40.3% higher specific tetanic force in LPS + CS + Mg group when compared to LPS + CS group. Histological analysis showed 4.1% higher proportion of muscle fibers area to total area and 63.6% lower intramuscular fat infiltration in EDL sections in LPS + CS + Mg group when compared to LPS + CS group. LPS + CS + Mg group had 33.0% higher area proportion and 29.4% higher cross-sectional area (CSA) of type IIb muscle fiber. Myoblast culture results showed that Mg++ supplementation group had larger myotube diameter. The mRNA expressions of the muscle atrophy marker genes MuRF1 and MAFbx were lower in Mg++ supplementation group both in vitro and in vivo. Conclusion: The current study demonstrated that Mg++ supplementation successfully alleviated CS-associated muscle atrophy in rats at both functional and morphology levels, indicating a translational potential for patients undergoing CS therapy. This study provided the evidence for the first time that Mg++ supplementation could prevent muscle atrophy—an adverse effect of CS therapy, currently also adopted for treating coronavirus disease 2019 (COVID-19).
      pubtype: Academic Journal
      doctype:
        diagnostic images
        equations & formulas
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N